These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23707924)
1. Development and validation of a quantitation assay for fluorescently tagged HIV-1 virus-like particles. Gutiérrez-Granados S; Cervera L; Gòdia F; Carrillo J; Segura MM J Virol Methods; 2013 Oct; 193(1):85-95. PubMed ID: 23707924 [TBL] [Abstract][Full Text] [Related]
2. Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium. Cervera L; Gutiérrez-Granados S; Martínez M; Blanco J; Gòdia F; Segura MM J Biotechnol; 2013 Jul; 166(4):152-65. PubMed ID: 23688724 [TBL] [Abstract][Full Text] [Related]
3. RMCE-based insect cell platform to produce membrane proteins captured on HIV-1 Gag virus-like particles. Vidigal J; Fernandes B; Dias MM; Patrone M; Roldão A; Carrondo MJT; Alves PM; Teixeira AP Appl Microbiol Biotechnol; 2018 Jan; 102(2):655-666. PubMed ID: 29143881 [TBL] [Abstract][Full Text] [Related]
4. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis. Kapur N; Thakral D; Durgapal H; Panda SK J Viral Hepat; 2012 Jun; 19(6):436-48. PubMed ID: 22571906 [TBL] [Abstract][Full Text] [Related]
6. Intracellular characterization of Gag VLP production by transient transfection of HEK 293 cells. Cervera L; González-Domínguez I; Segura MM; Gòdia F Biotechnol Bioeng; 2017 Nov; 114(11):2507-2517. PubMed ID: 28667757 [TBL] [Abstract][Full Text] [Related]
7. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins. Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074 [TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647 [TBL] [Abstract][Full Text] [Related]
9. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. Halsey RJ; Tanzer FL; Meyers A; Pillay S; Lynch A; Shephard E; Williamson AL; Rybicki EP Virus Res; 2008 May; 133(2):259-68. PubMed ID: 18329748 [TBL] [Abstract][Full Text] [Related]
10. Optimized production of HIV-1 virus-like particles by transient transfection in CAP-T cells. Gutiérrez-Granados S; Cervera L; Segura Mde L; Wölfel J; Gòdia F Appl Microbiol Biotechnol; 2016 May; 100(9):3935-47. PubMed ID: 26685677 [TBL] [Abstract][Full Text] [Related]
11. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Haglund K; Forman J; Kräusslich HG; Rose JK Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333 [TBL] [Abstract][Full Text] [Related]
12. Distinct Particle Morphologies Revealed through Comparative Parallel Analyses of Retrovirus-Like Particles. Martin JL; Cao S; Maldonado JO; Zhang W; Mansky LM J Virol; 2016 Sep; 90(18):8074-84. PubMed ID: 27356903 [TBL] [Abstract][Full Text] [Related]
13. Quantification of the HIV-1 virus-like particle production process by super-resolution imaging: From VLP budding to nanoparticle analysis. González-Domínguez I; Puente-Massaguer E; Cervera L; Gòdia F Biotechnol Bioeng; 2020 Jul; 117(7):1929-1945. PubMed ID: 32242921 [TBL] [Abstract][Full Text] [Related]
14. The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays. von Truchsess I; Harris B; Schätzl HM; Hackett J J Med Virol; 2006 Mar; 78(3):311-7. PubMed ID: 16419111 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397 [TBL] [Abstract][Full Text] [Related]
17. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures. Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267 [TBL] [Abstract][Full Text] [Related]
18. HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae. Sakuragi S; Goto T; Sano K; Morikawa Y Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7956-61. PubMed ID: 12060741 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. Respess RA; Cachafeiro A; Withum D; Fiscus SA; Newman D; Branson B; Varnier OE; Lewis K; Dondero TJ J Clin Microbiol; 2005 Jan; 43(1):506-8. PubMed ID: 15635029 [TBL] [Abstract][Full Text] [Related]
20. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. Ko YJ; Choi KS; Nah JJ; Paton DJ; Oem JK; Wilsden G; Kang SY; Jo NI; Lee JH; Kim JH; Lee HW; Park JM Clin Diagn Lab Immunol; 2005 Aug; 12(8):922-9. PubMed ID: 16085909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]